Moreover, the serum levels of CA15-3 (MUC-1), which is a mucinous glycoprotein, is another commonly used tumor marker for preclinical detection of tumour recurrence and metastasis, in addition to patients’ follow up10. Here, MUC1 is linked to neoplasm.